Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Data Sciences & AI

Data Sciences & AI

Enhanced decision-making for R&D

We offer end-to-end data solutions including data engineering, analytics, visualization, and data democratization. This is helping clients gain deeper insights into data and empowering their scientists with advanced analytics to accelerate R&D.

Predictive Modeling

Our data scientists build predictive models using diverse data types, including chemical and biological data, text, images and networks.
We have expertise with all unsupervised, machine learning and deep learning algorithms.


Automation and Analysis Pipelines

We build and deploy custom workflows for integrative analysis and diverse R&D applications.


SarchitectTM: Syngene Informatics platform

Our informatics platform integrates data and enables analytics and visualization, enabling informed decisions in R&D. The platform facilitates deployment of computational models to the scientists, enabling real-time “what if” analysis and ideation. We also offer custom solutions.

SarchitectTM : Our Data Analytics platform


Syn.AITM: Our platform for outcome-driven drug discovery

The Syngene artificial intelligence (AI) drug discovery platform enables deeper understanding of disease and network biology to identify and prioritize targets. It evaluates targets on multiple parameters pertaining to relevancy, druggability, and safety, thereby decreasing the later stage attrition.
The platform uses multiparameter optimization to explore chemical space and design molecules with the optimal balance of properties to meet the program objective faster.

Journey-updated

Syn.AITM : Syngene platform for AI-driven drug discovery

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details